Physician
Neurology
Dr. Sowmini K. Oomman, MD
Dr. Sowmini K. Oomman works in the field of Neurology. He studied medicine at University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is ranked 83/35 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Sowmini K. Oomman is a published MD as well. He has 10 publications published. The latest was: Non-aneurysmal perimesencephalic subarachnoid hemorrhage caused by a cavernous angioma. Sowmini K. Oomman, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
Procedures Preformed
- EEG (Electroencephalogram)
- Nerve Block, Somatic
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Coventry Health Care of Nebraska PPO
- First Health (Coventry Health Care) PPO
- Medicaid
- Medicare MCR
- Medico
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Arkansas for Medical Sciences
-
Kilpauk Medical College
Drug Facts
NPI NUMBER |
|
1043435068 |
NPPES Provider LastName |
|
OOMMAN |
NPPES Provider FirstName |
|
SOWMINI |
NPPES Provider ZIPCode |
|
691016579 |
NPPES Provider State |
|
NE |
Specialty Description |
|
Neurology |
Total Claim Count |
|
1250.0 |
Distinct Opioid Count |
|
1.0 |
Opioid Claim Count |
|
14.0 |
Percent Opioid Claims |
|
1.12 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1043435068 |
Last Name Of The Provider |
OOMMAN |
First Name Of The Provider |
SOWMINI |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog